305 related articles for article (PubMed ID: 25605528)
21. Changes of micro-RNAs in asymptomatic subjects sensitized to Japanese cedar pollen after prophylactic sublingual immunotherapy.
Hou B; Murata M; Said AS; Sakaida H; Masuda S; Takahashi T; Zhang Z; Takeuchi K
Allergy Rhinol (Providence); 2015 Jan; 6(1):33-8. PubMed ID: 25675113
[TBL] [Abstract][Full Text] [Related]
22. Treatment duration-dependent efficacy of Japanese cedar pollen sublingual immunotherapy: Evaluation of a phase II/III trial over three pollen dispersal seasons.
Yonekura S; Gotoh M; Kaneko S; Kanazawa K; Takeuji Y; Okubo K; Okamoto Y
Allergol Int; 2019 Oct; 68(4):494-505. PubMed ID: 31257168
[TBL] [Abstract][Full Text] [Related]
23. Effect of short-term oral immunotherapy with Cry j1-galactomannan conjugate on quality of life in Japanese cedar pollinosis patients: A prospective, randomized, open-label study.
Murakami D; Sawatsubashi M; Kikkawa S; Ejima M; Saito A; Kato A; Komune S
Auris Nasus Larynx; 2016 Feb; 43(1):50-5. PubMed ID: 26197940
[TBL] [Abstract][Full Text] [Related]
24. Effect of intranasal corticosteroid on pre-onset activation of eosinophils and mast cells in experimental Japanese cedar pollinosis.
Noyama Y; Okano M; Fujiwara T; Kariya S; Makihara S; Haruna T; Kanai K; Higaki T; Nishizaki K
Allergol Int; 2016 Jul; 65(3):259-65. PubMed ID: 26907728
[TBL] [Abstract][Full Text] [Related]
25. Immunological parameters associated with the development of allergic rhinitis: a preliminary prospective study.
Uekusa Y; Inamine A; Yonekura S; Horiguchi S; Fujimura T; Sakurai D; Yamamoto H; Suzuki H; Hanazawa T; Okamoto Y
Am J Rhinol Allergy; 2012; 26(2):92-6. PubMed ID: 22487284
[TBL] [Abstract][Full Text] [Related]
26. Safety profile and immunological response of dual sublingual immunotherapy with house dust mite tablet and Japanese cedar pollen tablet.
Gotoh M; Okubo K; Yuta A; Ogawa Y; Nagakura H; Ueyama S; Ueyama T; Kawashima K; Yamamoto M; Fujieda S; Sakashita M; Sakamoto H; Iwasaki N; Mori E; Endo T; Ohta N; Kitazawa H; Okano M; Asako M; Takada M; Terada T; Inaka Y; Yonekura S; Matsuoka T; Kaneko S; Hata H; Hijikata N; Tanaka H; Masuyama K; Okamoto Y
Allergol Int; 2020 Jan; 69(1):104-110. PubMed ID: 31421989
[TBL] [Abstract][Full Text] [Related]
27. [A study of aggravation of atopic dermatitis during Japanese cedar pollen season--correlation with grades of dermatitis on face and Cry j 1 specific IgE].
Aihara M; Takahashi S; Oosuna I; Yasueda H; Tsubaki K; Ikezawa Z
Arerugi; 1999 Oct; 48(10):1172-9. PubMed ID: 10554404
[TBL] [Abstract][Full Text] [Related]
28. Long-term treatment of Japanese cedar pollinosis with Japanese cedar pollen SLIT drops and persistence of treatment effect: A post-marketing clinical trial.
Nomura Y; Okubo K; Nakamura T; Sawaki S; Kitagou H; Idei N; Kaneko S; Kobayashi S; Tanaka Y; Okamoto Y
Allergol Int; 2021 Jan; 70(1):96-104. PubMed ID: 32653209
[TBL] [Abstract][Full Text] [Related]
29. An analysis of factors related to the effect of sublingual immunotherapy on Japanese cedar pollen induced allergic rhinitis.
Yonekura S; Okamoto Y; Sakurai D; Okubo K; Gotoh M; Kaneko S; Konno A
Allergol Int; 2018 Apr; 67(2):201-208. PubMed ID: 28760534
[TBL] [Abstract][Full Text] [Related]
30. Decreased numbers of metachromatic cells in nasal swabs in Japanese cedar pollinosis following sublingual immunotherapy.
Otsuka K; Otsuka H; Matsune S; Okubo K
Immun Inflamm Dis; 2020 Sep; 8(3):333-341. PubMed ID: 32468704
[TBL] [Abstract][Full Text] [Related]
31. Effect of Asian sand dust on Japanese cedar pollinosis.
Ogi K; Takabayashi T; Sakashita M; Susuki D; Yamada T; Manabe Y; Fujieda S
Auris Nasus Larynx; 2014 Dec; 41(6):518-22. PubMed ID: 24928063
[TBL] [Abstract][Full Text] [Related]
32. Long-Term Efficacy and Dose-Finding Trial of Japanese Cedar Pollen Sublingual Immunotherapy Tablet.
Gotoh M; Yonekura S; Imai T; Kaneko S; Horikawa E; Konno A; Okamoto Y; Okubo K
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1287-1297.e8. PubMed ID: 30537561
[TBL] [Abstract][Full Text] [Related]
33. Spectrum of allergens for Japanese cedar pollinosis and impact of component-resolved diagnosis on allergen-specific immunotherapy.
Fujimura T; Kawamoto S
Allergol Int; 2015 Oct; 64(4):312-20. PubMed ID: 26433527
[TBL] [Abstract][Full Text] [Related]
34. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Kunii N; Yamamoto H; Sakurai D; Hanazawa T
Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178
[TBL] [Abstract][Full Text] [Related]
35. Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen.
Rolinck-Werninghaus C; Kopp M; Liebke C; Lange J; Wahn U; Niggemann B
Int Arch Allergy Immunol; 2005 Feb; 136(2):134-41. PubMed ID: 15650310
[TBL] [Abstract][Full Text] [Related]
36. [CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY IN THE THIRD TREATED YEAR WITH JAPANESE CEDAR POLLINOSIS IN 2017].
Yuta A; Ogawa Y; Suzuki Y; Ogihara H; Ohta N; Kozaki H; Shimizu T
Arerugi; 2017; 66(9):1172-1180. PubMed ID: 29129888
[TBL] [Abstract][Full Text] [Related]
37. Preliminary Clinical Trial of Biomarkers to Predict Response to Sublingual Immunotherapy for Japanese Cedar Pollinosis.
Takahara E; Matsune S; Ishida M; Wakayama N; Okubo K
J Nippon Med Sch; 2020 Dec; 87(5):277-284. PubMed ID: 32074537
[TBL] [Abstract][Full Text] [Related]
38. Formation of IgE-Allergen-CD23 Complex Changes in Children Treated with Subcutaneous Immunotherapy for Japanese Cedar Pollinosis.
Asaumi T; Sato S; Yanagida N; Matsuhara H; Kobayashi S; Fukano C; Ohashi-Doi K; Ebisawa M
Int Arch Allergy Immunol; 2021; 182(3):190-194. PubMed ID: 33032294
[TBL] [Abstract][Full Text] [Related]
39. Japanese Cedar Pollen-Specific IgA in Nasal Secretions and Nasal Allergy Symptoms.
Suzuki M; Yokota M; Ozaki S; Matsumoto T; Nakamura Y
Ann Otol Rhinol Laryngol; 2019 Apr; 128(4):330-337. PubMed ID: 30678469
[TBL] [Abstract][Full Text] [Related]
40. A randomized double-blind comparative study of sublingual immunotherapy for cedar pollinosis.
Okubo K; Gotoh M; Fujieda S; Okano M; Yoshida H; Morikawa H; Masuyama K; Okamoto Y; Kobayashi M
Allergol Int; 2008 Sep; 57(3):265-75. PubMed ID: 18566549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
